HealthKart Secures $153M Funding to Accelerate Growth

India’s largest omnichannel nutrition platform, HealthKart, has closed a $153 million funding round led by ChrysCapital and Motilal Oswal Alternates, with participation from Neo Group and existing investor A91 Partners. Avendus Capital advised on the transaction.

The company hit a major milestone in FY24 by crossing Rs 1,000 crore in revenue and achieving EBITDA profitability for the year. HealthKart is focused on building its leading brands and expanding internationally.

HealthKart also rolled out its first-ever employee ESOP buyback programme worth Rs 55 crore, benefiting current and former employees who have been integral to the company’s success.

“We welcome ChrysCapital and Motilal Oswal to HealthKart and hope to leverage their expertise during the next phase of growth,” said Sameer Maheshwari, Founder & CEO of HealthKart.

“We are also very excited about our first ESOP buyback program which will create meaningful value for people who have played a critical role in building HealthKart. We firmly believe that people are our greatest asset and we aim to align their personal success with the company’s long-term vision.”

Commenting on this announcement, Arpit Vinayak, Vice-President, ChrysCapital said, “ChrysCapital is excited to partner with HealthKart as it embarks on its growth journey. The Indian sports nutrition market, currently underpenetrated, is expected to expand due to a rise in fitness awareness and the increasing importance of nutrition and protein.” – TWL Bureau